Return on Equity (ROE)
since 2005
Paying user area
Try for free
Abiomed Inc. pages available for free this week:
- Cash Flow Statement
- Common-Size Balance Sheet: Assets
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abiomed Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Abiomed Inc., ROE, long-term trends, calculation
| ROE | = | 100 | × | Net income (loss)1 | ÷ | Stockholders’ equity1 | |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | = | 100 | × | ÷ | |||
| Mar 31, 2021 | = | 100 | × | ÷ | |||
| Mar 31, 2020 | = | 100 | × | ÷ | |||
| Mar 31, 2019 | = | 100 | × | ÷ | |||
| Mar 31, 2018 | = | 100 | × | ÷ | |||
| Mar 31, 2017 | = | 100 | × | ÷ | |||
| Mar 31, 2016 | = | 100 | × | ÷ | |||
| Mar 31, 2015 | = | 100 | × | ÷ | |||
| Mar 31, 2014 | = | 100 | × | ÷ | |||
| Mar 31, 2013 | = | 100 | × | ÷ | |||
| Mar 31, 2012 | = | 100 | × | ÷ | |||
| Mar 31, 2011 | = | 100 | × | ÷ | |||
| Mar 31, 2010 | = | 100 | × | ÷ | |||
| Mar 31, 2009 | = | 100 | × | ÷ | |||
| Mar 31, 2008 | = | 100 | × | ÷ | |||
| Mar 31, 2007 | = | 100 | × | ÷ | |||
| Mar 31, 2006 | = | 100 | × | ÷ | |||
| Mar 31, 2005 | = | 100 | × | ÷ |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$ in thousands
The financial data reveals significant fluctuations in net income over the examined periods. Initially, there are substantial losses from 2005 through 2011, peaking in magnitude around 2006 and 2008. Starting in 2012, the company transitions into profitability, with net income showing consistent positive growth and reaching a pronounced peak in 2019. The highest net income value occurs in 2019, followed by a decline in the subsequent years, though income remains positive through 2022.
Stockholders’ equity shows a steady and strong upward trend throughout the period. From an initial figure of approximately 56 million USD in 2005, it grows consistently nearly every year, reaching over 1.5 billion USD by 2022. This continuous increase suggests ongoing capital accumulation and retained earnings, reflecting an improving financial foundation.
The Return on Equity (ROE) metric exhibits high volatility aligned with the net income trends. From significantly negative percentages in the early years, indicative of losses, ROE gradually improves, turning positive starting in 2012. Following this, the ROE trend generally ascends, reaching a peak in 2019 at 27.65%, signaling efficient utilization of shareholders' equity during that year. The subsequent years show a decline but maintain positive values, indicating sustained profitability albeit with reduced efficiency compared to the peak year.
- Net Income (Loss)
- Substantial losses in initial years, transitioning to profitability post-2011 with a peak in 2019, followed by a decrease but positive income in later years.
- Stockholders’ Equity
- Continuous growth across all years, indicating strengthening capital structure and accumulation of retained earnings.
- Return on Equity (ROE)
- Negative in early years due to losses, turning positive from 2012 onward with a peak efficiency in 2019, followed by moderate declines while remaining positive.
Comparison to Competitors
Abiomed Inc., ROE, long-term trends, comparison to competitors
| Abiomed Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Mar 31, 2022 | ||||||
| Mar 31, 2021 | ||||||
| Mar 31, 2020 | ||||||
| Mar 31, 2019 | ||||||
| Mar 31, 2018 | ||||||
| Mar 31, 2017 | ||||||
| Mar 31, 2016 | ||||||
| Mar 31, 2015 | ||||||
| Mar 31, 2014 | ||||||
| Mar 31, 2013 | ||||||
| Mar 31, 2012 | ||||||
| Mar 31, 2011 | ||||||
| Mar 31, 2010 | ||||||
| Mar 31, 2009 | ||||||
| Mar 31, 2008 | ||||||
| Mar 31, 2007 | ||||||
| Mar 31, 2006 | ||||||
| Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Sector (Health Care Equipment & Services)
Abiomed Inc., ROE, long-term trends, comparison to sector (health care equipment & services)
| Abiomed Inc. | Health Care Equipment & Services | |
|---|---|---|
| Mar 31, 2022 | ||
| Mar 31, 2021 | ||
| Mar 31, 2020 | ||
| Mar 31, 2019 | ||
| Mar 31, 2018 | ||
| Mar 31, 2017 | ||
| Mar 31, 2016 | ||
| Mar 31, 2015 | ||
| Mar 31, 2014 | ||
| Mar 31, 2013 | ||
| Mar 31, 2012 | ||
| Mar 31, 2011 | ||
| Mar 31, 2010 | ||
| Mar 31, 2009 | ||
| Mar 31, 2008 | ||
| Mar 31, 2007 | ||
| Mar 31, 2006 | ||
| Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Industry (Health Care)
Abiomed Inc., ROE, long-term trends, comparison to industry (health care)
| Abiomed Inc. | Health Care | |
|---|---|---|
| Mar 31, 2022 | ||
| Mar 31, 2021 | ||
| Mar 31, 2020 | ||
| Mar 31, 2019 | ||
| Mar 31, 2018 | ||
| Mar 31, 2017 | ||
| Mar 31, 2016 | ||
| Mar 31, 2015 | ||
| Mar 31, 2014 | ||
| Mar 31, 2013 | ||
| Mar 31, 2012 | ||
| Mar 31, 2011 | ||
| Mar 31, 2010 | ||
| Mar 31, 2009 | ||
| Mar 31, 2008 | ||
| Mar 31, 2007 | ||
| Mar 31, 2006 | ||
| Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).